These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 33101195

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Primary aldosteronism and essential hypertension: assessment of cardiovascular risk at diagnosis and after treatment.
    Turchi F, Ronconi V, di Tizio V, Ceccoli L, Boscaro M, Giacchetti G.
    Nutr Metab Cardiovasc Dis; 2014 May; 24(5):476-82. PubMed ID: 24630976
    [Abstract] [Full Text] [Related]

  • 4. A possible association between primary aldosteronism and a lower beta-cell function.
    Mosso LM, Carvajal CA, Maiz A, Ortiz EH, Castillo CR, Artigas RA, Fardella CE.
    J Hypertens; 2007 Oct; 25(10):2125-30. PubMed ID: 17885557
    [Abstract] [Full Text] [Related]

  • 5. Metabolic syndrome in primary aldosteronism and essential hypertension: relationship to adiponectin gene variants.
    Ronconi V, Turchi F, Rilli S, Di Mattia D, Agostinelli L, Boscaro M, Giacchetti G.
    Nutr Metab Cardiovasc Dis; 2010 Feb; 20(2):93-100. PubMed ID: 19481913
    [Abstract] [Full Text] [Related]

  • 6. Clinical Characteristics of Target Organ Damage in Primary Aldosteronism with or without Metabolic Syndrome.
    Bu X, Sun F, Zhang H, Liu X, Zhao Z, He H, Li Y, Yan Z, Zhu Z.
    J Diabetes Res; 2022 Feb; 2022():8932133. PubMed ID: 36117521
    [Abstract] [Full Text] [Related]

  • 7. Higher prevalence of metabolic disorders in patients with bilateral primary aldosteronism than unilateral primary aldosteronism.
    Zhang Z, Luo Q, Tuersun T, Wang G, Wu T, Zhang D, Wang M, Zhou K, Sun L, Yue N, Li N.
    Clin Endocrinol (Oxf); 2021 Jan; 94(1):3-11. PubMed ID: 32810877
    [Abstract] [Full Text] [Related]

  • 8. Blood pressure, thyroid-stimulating hormone, and thyroid disease prevalence in primary aldosteronism and essential hypertension.
    Turchi F, Ronconi V, di Tizio V, Boscaro M, Giacchetti G.
    Am J Hypertens; 2011 Dec; 24(12):1274-9. PubMed ID: 21850059
    [Abstract] [Full Text] [Related]

  • 9. Association Between Metabolic Syndrome and Parameters of Subclinical Target Organ Damage in Urban Subjects Without Documented Cardiovascular Disease.
    Kim HL, Joo HJ, Lim WH, Seo JB, Kim SH, Zo JH, Lim DS, Kim MA.
    Metab Syndr Relat Disord; 2020 Oct; 18(8):373-380. PubMed ID: 32721264
    [Abstract] [Full Text] [Related]

  • 10. Abdominal aortic calcification is more severe in unilateral primary aldosteronism patients and is associated with elevated aldosterone and parathyroid hormone levels.
    Tuersun T, Luo Q, Zhang Z, Wang G, Zhang D, Wang M, Wu T, Zhou K, Yue N, Li N.
    Hypertens Res; 2020 Dec; 43(12):1413-1420. PubMed ID: 32770102
    [Abstract] [Full Text] [Related]

  • 11. Comparison of Clinical Features between Primary Aldosteronism and Essential Hypertension in Chinese Patients: A Case-Control Study.
    Huang X, Yu S, Xiao H, Pei L, Chen Y, Chen W, Li Y, Xiao H, Cao X.
    Int J Endocrinol; 2021 Dec; 2021():6685469. PubMed ID: 34194493
    [Abstract] [Full Text] [Related]

  • 12. Adipokines and cardiometabolic profile in primary hyperaldosteronism.
    Iacobellis G, Petramala L, Cotesta D, Pergolini M, Zinnamosca L, Cianci R, De Toma G, Sciomer S, Letizia C.
    J Clin Endocrinol Metab; 2010 May; 95(5):2391-8. PubMed ID: 20194710
    [Abstract] [Full Text] [Related]

  • 13. The prevalence of primary aldosteronism in diabetic patients.
    Jefic D, Mohiuddin N, Alsabbagh R, Fadanelli M, Steigerwalt S.
    J Clin Hypertens (Greenwich); 2006 Apr; 8(4):253-6. PubMed ID: 16596027
    [Abstract] [Full Text] [Related]

  • 14. Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study.
    Savard S, Amar L, Plouin PF, Steichen O.
    Hypertension; 2013 Aug; 62(2):331-6. PubMed ID: 23753408
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hemodynamic and Non-Hemodynamic Components of Cardiac Remodeling in Primary Aldosteronism.
    Pan CT, Wu XM, Tsai CH, Chang YY, Chen ZW, Chang CC, Lee BC, Liao CW, Chen YL, Lin LC, Chang YR, Hung CS, Lin YH.
    Front Endocrinol (Lausanne); 2021 Aug; 12():646097. PubMed ID: 33953695
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Biomarkers of endothelial dysfunction and risk of early organ damage: a comparison between patients with primary aldosteronism and essential hypertension].
    Liu G, Zhang SL, Liu PM, Yin GS, Tang JY, Ma DJ, Yan L, Wang JF.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Aug; 40(8):640-4. PubMed ID: 23141006
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.